| Intracranial Aneurysms: Treatment and Complications | Lifetime | 34 | DE 1 | 99.73 |
| Moyamoya disease diagnosis and treatment | Lifetime | 12 | DE 2 | 99.44 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 87 | DE 4 | 99.65 |
| Angiogenesis and VEGF in Cancer | Lifetime | 92 | DE 12 | 99.28 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 263 | DE 21 | 99.21 |
| Glioma Diagnosis and Treatment | Lifetime | 213 | DE 30 | 99.26 |
| Neurosurgical Procedures and Complications | Lifetime | 68 | DE 6 | 99.22 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 287 | DE 20 | 99.16 |
| Neurological Complications and Syndromes | Lifetime | 51 | DE 5 | 98.79 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 161 | DE 10 | 98.43 |
| Intraoperative Neuromonitoring and Anesthetic Effects | Lifetime | 30 | DE 5 | 97.97 |
| Meningioma and schwannoma management | Lifetime | 249 | DE 29 | 98.57 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 269 | DE 18 | 98.06 |
| Immune cells in cancer | Lifetime | 667 | DE 63 | 96.65 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 823 | DE 73 | 97.45 |
| Acute Ischemic Stroke Management | Lifetime | 976 | DE 87 | 97.48 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 427 | DE 30 | 96.94 |
| Phagocytosis and Immune Regulation | Lifetime | 376 | DE 31 | 94.32 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 591 | DE 84 | 95.71 |
| Management of metastatic bone disease | Lifetime | 562 | DE 30 | 94.40 |
| Optical Imaging and Spectroscopy Techniques | Lifetime | 658 | DE 52 | 94.19 |
| Brain Metastases and Treatment | Lifetime | 888 | DE 76 | 94.96 |
| Barrier Structure and Function Studies | Lifetime | 811 | DE 92 | 87.03 |
| Cerebrovascular and genetic disorders | Lifetime | 714 | DE 36 | 79.56 |
| Intracranial Aneurysms: Treatment and Complications | 2021-2025 | 19 | DE 2 | 99.06 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 78 | DE 4 | 98.62 |
| Chemokine receptors and signaling | 2021-2025 | 20 | DE 7 | 92.57 |
| Glioma Diagnosis and Treatment | 2021-2025 | 445 | DE 71 | 96.09 |
| Neurosurgical Procedures and Complications | 2021-2025 | 95 | DE 8 | 95.04 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 43 | DE 3 | 90.84 |
| Neurological Complications and Syndromes | 2021-2025 | 39 | DE 2 | 93.67 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 66 | DE 3 | 91.90 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 235 | DE 11 | 92.33 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 551 | DE 35 | 91.70 |
| Brain Metastases and Treatment | 2021-2025 | 351 | DE 47 | 91.38 |
| Cerebrospinal fluid and hydrocephalus | 2021-2025 | 375 | DE 17 | 88.07 |
| Spinal Fractures and Fixation Techniques | 2021-2025 | 703 | DE 19 | 90.65 |
| Management of metastatic bone disease | 2021-2025 | 253 | DE 13 | 87.44 |
| Vascular Malformations Diagnosis and Treatment | 2021-2025 | 369 | DE 35 | 88.30 |
| Meningioma and schwannoma management | 2021-2025 | 607 | DE 74 | 88.30 |
| Intraoperative Neuromonitoring and Anesthetic Effects | 2021-2025 | 54 | DE 7 | 83.67 |
| Surgical Simulation and Training | 2021-2025 | 571 | DE 47 | 85.21 |
| Axon Guidance and Neuronal Signaling | 2021-2025 | 66 | DE 5 | 79.17 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 651 | DE 56 | 83.18 |
| Medical Imaging and Analysis | 2021-2025 | 714 | DE 36 | 80.68 |
| S100 Proteins and Annexins | 2021-2025 | 391 | DE 25 | 73.93 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 473 | DE 34 | 73.32 |
| Pain Management and Treatment | 2021-2025 | 610 | DE 30 | 70.98 |
| Facial Nerve Paralysis Treatment and Research | 2021-2025 | 614 | DE 39 | 68.98 |
| Anatomy and Medical Technology | 2021-2025 | 966 | DE 102 | 67.41 |
| Peripheral Nerve Disorders | 2021-2025 | 882 | DE 46 | 61.85 |
| Hippo pathway signaling and YAP/TAZ | 2021-2025 | 855 | DE 39 | 55.62 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 415 | DE 26 | 49.42 |
